Retrospective study of ocular surface squamous neoplasia

被引:85
作者
Lee, GA [1 ]
Hirst, LW [1 ]
机构
[1] PRINCESS ALEXANDRA HOSP,DEPT SURG,DIV OPHTHALMOL,BRISBANE,QLD 4102,AUSTRALIA
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY | 1997年 / 25卷 / 04期
关键词
carcinoma in situ; dysplasia; ocular surface squamous neoplasia; squamous cell carcinoma;
D O I
10.1111/j.1442-9071.1997.tb01514.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Ocular surface squamous neoplasia (OSSN) encompasses the conditions of simple dysplasia to carcinoma in situ to invasive squamous cell carcinoma. it has a high rate of recurrence after treatment and the potential to metastasize. The present retrospective study was aimed at further defining the characteristics and clinical course of OSSN. Methods: With ethical approval, the records of all major pathology laboratories in Queensland were surveyed. Two hundred and eighty-eight cases were identified: 155 dysplasia, 71 carcinomas in situ and 62 invasive squamous cell carcinoma. The records were analysed and an attempt was made to contact and re-examine the patients. Results: Ocular surface squamous neoplasia occurs mainly in males (78.5%) with a mean age of 60.1 years (range 20-88 years). They present as irritation (40.1%) and are located usually at the limbus (87.8%). The majority of OSSN are treated by simple excision (87.5%), after which there is a high rate of recurrence (23.3%). The main predictors for recurrence include histological grade of the lesion, corneal location and larger size (> 2 mm). Conclusions: Management of OSSN requires adequate excision and careful follow up to monitor any recurrence. As with other ultraviolet light-related conditions, preventative measures must remain the key to disease control.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 20 条
[11]  
MAHONEY MC, 1990, OPHTHALMOLOGY, V97, P1143
[12]  
MALIK MOA, 1979, CANCER, V44, P293, DOI 10.1002/1097-0142(197907)44:1<293::AID-CNCR2820440150>3.0.CO
[13]  
2-R
[14]  
MCDONNELL JM, 1992, INVEST OPHTH VIS SCI, V33, P184
[15]  
NI C, 1982, International Ophthalmology Clinics, V22, P1
[16]  
PEKSAYAR G, 1989, AM J OPHTHALMOL, V15, P337
[17]  
*STAT EP RES CORP, 1989, EGRET STAT PACK
[18]  
TABBARA KF, 1988, OPHTHALMOLOGY, V95, P318
[19]  
TEMPLETON AC, 1967, CANCER-AM CANCER SOC, V20, P1689, DOI 10.1002/1097-0142(196710)20:10<1689::AID-CNCR2820201019>3.0.CO
[20]  
2-F